Delivery Order SPE2DR25D1205-SPE2DR26F1AF9
- Not listed
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a $12,536.26 firm fixed-price delivery order for INLYTA 5 mg tablets (60-count units) with an ultimate completion date of January 16, 2026. This non-set-aside contract was competitively awarded on December 24, 2025, with performance taking place at the vendor's corporate office location in Conshohocken, Pennsylvania. The delivery order is a child contract issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a $12,536.26 delivery order to AmerisourceBergen Drug Corp for 60 tablets of INLYTA 5 mg, a pharmaceutical product for medical supply fulfillment. This firm fixed-price delivery order, issued on December 4, 2025, with completion scheduled for December 26, 2025, will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award utilized competitive procurement procedures with no set-aside designation, reflecting...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The $10,710.96 firm fixed price delivery order is for the supply of INLYTA 1 MG TABLET 180S, a prescription medication, with a completion date of February 21, 2024. Amerisourcebergen Drug Corp, through its Corporate Office division located in Conshohocken, Pennsylvania,...
- The Defense Logistics Agency awarded a $12.6K firm fixed-price delivery order to AmerisourceBergen Drug Corp for supply of Inlyta 1 mg tablets (180-count units), with a completion date of January 23, 2026. This non-set-aside contract represents a standard pharmaceutical procurement for federal medical supply needs. AmerisourceBergen, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for military and veteran healthcare systems through...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency (DLA) for INLYTA 5 mg tablets (60-count) on July 25, 2025. The contract is a firm fixed-price delivery order with a ceiling value of $11,895.72 and an ultimate completion date of August 15, 2025. This award was made through open competition with no set-aside designation and represents a child contract under AmerisourceBergen's...
- This federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) to provide 4,567,104,556 units of the 5 mg tablet form of the prescription drug Inlyta. The $11,421.17 firm fixed-price delivery order has a completion date of February 21, 2025. This contract is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, which serves as a primary vehicle...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $32,057.76 firm fixed-price delivery order is for the supply of Inlyta 5 mg tablets. The contract has an ultimate completion date of January 30, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
- This is a $11,039.62 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The order is for the supply of 4,565,077,706 tablets of the prescription drug Inlyta (5 mg) to support federal government medical requirements. Amerisourcebergen is a major pharmaceutical distributor that holds a single-award Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999.00 through December...
- Amerisourcebergen Drug Corporation, a division of Amerisourcebergen Corporation, has been awarded a firm fixed price delivery order valued at ten thousand six hundred eighty five dollars and ninety two cents ($10,685.92) by the Defense Logistics Agency Troop Support Medical to supply sixty (60) 5 mg tablets of INLYTA, an oral medication used to treat advanced kidney cancer. Performance will take place at Amerisourcebergen's facility in Conshohocken, Pennsylvania over a period extending from...
- This federal contract award is for the delivery of INLYTA 1 MG TABLET 180S to the Defense Logistics Agency (DLA) Troop Support Medical. The prime contractor is Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The contract is a firm fixed price delivery order with a potential value of $10,710.96 and a completion date of March 6, 2024. It is not designated as a set-aside contract....
- SPE2DR25D1205Indefinite Delivery Contract
- SPE2DR25D1205-SPE2DR26F1AF9Delivery Order
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency on January 20, 2026, for INLYTA 5 mg tablets (60-count supply) with a ceiling value of $12,536.26. The contract is structured as a firm fixed-price delivery order with an ultimate completion date of February 10, 2026. This award was not set-aside and represents a competitive procurement action. The delivery order is executed under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs. AmerisourceBergen operates as a subsidiary of Cencora, Inc. (formerly doing business as AmerisourceBergen), which holds the parent IDC with DLA Troop Support Medical. The supply chain relationship reflects Cencora's role as a critical federal medical procurement vendor specializing in a broad range of pharmaceutical products, medical supplies, and healthcare commodities for military treatment facilities, veterans' healthcare systems, and other government medical institutions. The award demonstrates the contractor's capability to deliver specialty medications efficiently through the established DLA framework supporting Department of Defense healthcare requirements.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $12.5k | 1/19/26 |